Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial

Schwartz, GG; Nicholls, SJ; Toth, PP; Sweeney, M; Halliday, C; Johansson, JO; Wong, NCW; Kulikowski, E; Kalantar-Zadeh, K; Ginsberg, HN; Ray, KK

Schwartz, GG (corresponding author), Univ Colorado, Sch Med, Div Cardiol, 1700 N Wheeling St,Cardiol 111B, Aurora, CO 80045 USA.

CARDIOVASCULAR DIABETOLOGY, 2021; 20 (1):

Abstract

Background In stable patients with type 2 diabetes (T2D), insulin treatment is associated with elevated risk for major adverse cardiovascular events (......

Full Text Link